The AATB biennial election for 2022-2024 Council Officers opens June 1.

AATB is seeking nominations for the eight AATB councils in the following leadership positions: Chairperson, Vice-Chairperson, and Secretary.

AATB's legal counsel sent an email to the FDA Office of Chief Counsel requesting a meeting to discuss potential litigation against the FDA regarding its reclassification of human acellular dermal matrix (hADM) allografts for post-mastectomy breast reconstruction.

Blood Centers of America (BCA) and the American Association of Tissue Banks (AATB) have partnered to provide value to its accredited institutional members with aggregated purchasing power and critical supply management services. 

The Centers for Medicare & Medicaid Services have rescinded their February 23, 2022 mandate to broadly deny claims for “manipulated amniotic and/or placental tissue biologics for injections to treat illness.”

AATB submitted the below letter in response to the Centers for Medicare and Medicaid Services (CMS) Request for Information (RFI) on Health and Safety Requirements for Transplant Programs, Organ Procurement Organizations, and End-Stage Renal Disease Facilities.

Two NEW self-paced learning module programs are now available in the

AATB is pleased to announce the incoming 2021-2023 Officers and At-Large members of the Board of Governors. The term for the incoming 2021-2023 Board of Governors Officers and At-Large Members will begin at the conclusion of the AATB Annual Business Meeting, Wednesday, October 13, 2021.

The AATB Board of Governors released the below tax status statement in support of their members.